Acute Spinal Cord Injury
28
10
10
8
Key Insights
Highlights
Success Rate
73% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.7%
3 terminated out of 28 trials
72.7%
-13.8% vs benchmark
14%
4 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (28)
tSCI Contrast Enhanced Ultrasound Study
Spinal Cord Injury Neuroprotection With Glyburide
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury
TSCS for Acute SCI
Early FES Cycling in Acute Spinal Cord Injury for Neuromuscular Preservation and Neurorecovery
Early Intervention for Information Processing Speed Deficits in Acute SCI: A Pilot Study
A Pilot RCT to Improve Cognitive Processing Speed in Acute SCI
Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI
Stem Cells in Spinal Cord Injury
Spasticity and Functional Recovery After SCI
Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury
Spinal Cord Injury Neuroprotection With Glyburide